Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 30, 2019 Filed Sep 3, 2019 16:22 UTC |
PHILLIPS CHARLES G IIIDirector
|
SaleOrdinary Shares | 12,908 | $91.46 | $1,180,539.86 |
DisclosureSEC source: 0001209191-19-047959 · doc4.xml · nonDerivative · entry 3 PHILLIPS CHARLES G III · CIK 0001129246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,904 F2 · price: On August 30, 2019, Mr. Phillips sold 12,908 shares in multiple trades at prices ranging from $90.93 to $91.92. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 30, 2019 Filed Sep 3, 2019 16:22 UTC |
PHILLIPS CHARLES G IIIDirector
|
SaleOrdinary Shares | 8,692 | $90.63 | $787,738.58 |
DisclosureSEC source: 0001209191-19-047959 · doc4.xml · nonDerivative · entry 2 PHILLIPS CHARLES G III · CIK 0001129246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,812 F1 · price: On August 30, 2019, Mr. Phillips sold 8,692 shares in multiple trades at prices ranging from $89.92 to $90.91. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 30, 2019 Filed Sep 3, 2019 16:22 UTC |
PHILLIPS CHARLES G IIIDirector
|
Exercise / conversionOrdinary Shares | 22,000 | $6.72 | $147,840.00 |
DisclosureSEC source: 0001209191-19-047959 · doc4.xml · nonDerivative · entry 1 PHILLIPS CHARLES G III · CIK 0001129246 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 20:24 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 500 | $92.00 | $46,000.00 |
DisclosureSEC source: 0001209191-19-047965 · doc4.xml · nonDerivative · entry 3 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,601 Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 20:24 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 65,768 | $91.60 | $6,024,611.87 |
DisclosureSEC source: 0001209191-19-047965 · doc4.xml · nonDerivative · entry 2 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,101 F2 · price: On August 29, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 65,768 shares in multiple trades at prices ranging from $91.00 to $91.99. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 20:24 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 57,913 | $90.58 | $5,245,585.80 |
DisclosureSEC source: 0001209191-19-047965 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,869 F1 · price: On August 29, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 57,913 shares in multiple trades at prices ranging from $90.00 to $90.995. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 20:20 UTC |
VERNON W ANTHONYDirector
|
SaleOrdinary Shares | 100,000 | $91.03 | $9,103,100.00 |
DisclosureSEC source: 0001209191-19-047956 · doc4.xml · nonDerivative · entry 1 VERNON W ANTHONY · CIK 0001369091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,589 F1 · price: On August 29, 2019, Mr. Vernon sold 100,000 shares in multiple trades at prices ranging from $91.00 to $91.14. The price reported above reflects the weighted average sale price. Mr. Vernon hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 20:39 UTC |
Shah PriteshChief Commercial Officer
|
OtherOrdinary Shares | 13,835 | $97.80 | $1,353,063.00 |
DisclosureSEC source: 0001209191-19-047412 · doc4.xml · nonDerivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,141 F1 · kind: Private sale transaction. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:18 UTC |
LEUNG GABRIELDirector
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 5,000 | $0.00 Strike: $3.44 | $0.00 |
DisclosureSEC source: 0001209191-19-045896 · doc4.xml · derivative · entry 3 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,743 Underlying: Ordinary Shares · 5,000 shares Expires 2021-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:18 UTC |
LEUNG GABRIELDirector
|
SaleOrdinary Shares | 5,000 | $86.45 | $432,250.00 |
DisclosureSEC source: 0001209191-19-045896 · doc4.xml · nonDerivative · entry 2 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,504 F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:18 UTC |
LEUNG GABRIELDirector
|
Exercise / conversionOrdinary Shares | 5,000 | $3.44 | $17,200.00 |
DisclosureSEC source: 0001209191-19-045896 · doc4.xml · nonDerivative · entry 1 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 20:43 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 1,813 | $85.23 | $154,521.99 |
DisclosureSEC source: 0001209191-19-044836 · doc4.xml · nonDerivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,976 F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 20:13 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 1,905 | $83.20 | $158,501.72 |
DisclosureSEC source: 0001209191-19-044234 · doc4.xml · nonDerivative · entry 4 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,789 F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 20:13 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,718 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-044234 · doc4.xml · derivative · entry 6 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,434 Underlying: Ordinary Shares · 3,718 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Fully vested as of the date hereof. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 20:13 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOptions to buy Ordinary Shares · Derivative | 5,115 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001209191-19-044234 · doc4.xml · derivative · entry 5 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,343 Underlying: Ordinary Shares · 5,115 shares Expires 2028-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 20:13 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOrdinary Shares | 3,718 | $83.30 | $309,709.40 |
DisclosureSEC source: 0001209191-19-044234 · doc4.xml · nonDerivative · entry 3 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 20:13 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 5,115 | $82.92 | $424,135.80 |
DisclosureSEC source: 0001209191-19-044234 · doc4.xml · nonDerivative · entry 2 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,976 F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 20:13 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOrdinary Shares | 5,115 | $34.00 | $173,910.00 |
DisclosureSEC source: 0001209191-19-044234 · doc4.xml · nonDerivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah. Read SEC document |
| July 30, 2019 Filed Aug 1, 2019 20:10 UTC |
Benaim ElyChief Medical Officer
|
GrantOptions to Buy Ordinary Shares · Derivative | 5,206 | $0.00 Strike: $83.30 | $0.00 |
DisclosureSEC source: 0001209191-19-044006 · doc4.xml · derivative · entry 2 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,206 Underlying: Ordinary Shares · 5,206 shares Expires 2029-07-30 F2 · derivative.exercise_date: Options to buy 5,206 ordinary shares will fully vest and become exercisable in equal installments on each of July 30, 2020, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates. Read SEC document |
| July 30, 2019 Filed Aug 1, 2019 20:10 UTC |
Benaim ElyChief Medical Officer
|
GrantRestricted Stock Units | 3,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-044006 · doc4.xml · nonDerivative · entry 1 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,617 F1 · shares: One-third of these restricted stock units are scheduled to vest on each of July 30, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates. Read SEC document |
| July 30, 2019 Filed Aug 1, 2019 20:12 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
GrantOptions to Buy Ordinary Shares · Derivative | 10,412 | $0.00 Strike: $83.30 | $0.00 |
DisclosureSEC source: 0001209191-19-044010 · doc4.xml · derivative · entry 2 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,412 Underlying: Ordinary Shares · 10,412 shares Expires 2029-07-30 F1 · security: These equity awards were granted to Mr. Doyle in recognition of his accomplishments related to Medicare coverage and pricing. F3 · derivative.exercise_date: Options to buy 10,412 ordinary shares will vest and become exercisable in equal installments on each of July 30, 2020, 2021, 2022 and 2023, subject to the reporting person's continued employment through such dates. Read SEC document |
| July 30, 2019 Filed Aug 1, 2019 20:12 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
GrantRestricted Stock Units | 6,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-044010 · doc4.xml · nonDerivative · entry 1 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 852,465 F1 · security: These equity awards were granted to Mr. Doyle in recognition of his accomplishments related to Medicare coverage and pricing. F2 · shares: One-third of these restricted stock units are scheduled to vest on each of July 30, 2020, 2021 and 2022, subject to the reporting person's continued employment through such dates. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:57 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOptions to buy Ordinary Shares · Derivative | 12,500 | $0.00 Strike: $19.25 | $0.00 |
DisclosureSEC source: 0001209191-19-043642 · doc4.xml · derivative · entry 8 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Options to buy Ordinary Shares · 12,500 shares Expires 2027-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:57 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 100 | $80.06 | $8,006.00 |
DisclosureSEC source: 0001209191-19-043642 · doc4.xml · nonDerivative · entry 7 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,976 F6 · price: On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $78.97 to $79.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:57 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 3,857 | $79.41 | $306,288.23 |
DisclosureSEC source: 0001209191-19-043642 · doc4.xml · nonDerivative · entry 6 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,076 F5 · price: On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $77.94 to $78.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:57 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 2,455 | $78.68 | $193,149.58 |
DisclosureSEC source: 0001209191-19-043642 · doc4.xml · nonDerivative · entry 5 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,933 F5 · price: On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $77.94 to $78.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:57 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 2,800 | $77.28 | $216,375.60 |
DisclosureSEC source: 0001209191-19-043642 · doc4.xml · nonDerivative · entry 4 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,388 F4 · price: On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $76.88 to $77.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:57 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 2,710 | $76.39 | $207,016.90 |
DisclosureSEC source: 0001209191-19-043642 · doc4.xml · nonDerivative · entry 3 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,188 F3 · price: On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $75.86 to $76.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:57 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 578 | $75.04 | $43,371.96 |
DisclosureSEC source: 0001209191-19-043642 · doc4.xml · nonDerivative · entry 2 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,898 F2 · price: On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $74.80 to $75.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:57 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOrdinary Shares | 12,500 | $19.25 | $240,625.00 |
DisclosureSEC source: 0001209191-19-043642 · doc4.xml · nonDerivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah. Read SEC document |
| July 18, 2019 Filed Jul 22, 2019 14:47 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 7,500 | $0.00 Strike: $27.60 | $0.00 |
DisclosureSEC source: 0001209191-19-042854 · doc4.xml · derivative · entry 3 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Ordinary Shares · 7,500 shares Expires 2028-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| July 18, 2019 Filed Jul 22, 2019 14:47 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 7,500 | $70.00 | $525,000.00 |
DisclosureSEC source: 0001209191-19-042854 · doc4.xml · nonDerivative · entry 2 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,976 F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah. Read SEC document |
| July 18, 2019 Filed Jul 22, 2019 14:47 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOrdinary Shares | 7,500 | $27.60 | $207,000.00 |
DisclosureSEC source: 0001209191-19-042854 · doc4.xml · nonDerivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:04 UTC |
LEUNG GABRIELDirector
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 5,000 | $0.00 Strike: $3.44 | $0.00 |
DisclosureSEC source: 0001209191-19-041912 · doc4.xml · derivative · entry 3 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,743 Underlying: Ordinary Shares · 5,000 shares Expires 2021-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:04 UTC |
LEUNG GABRIELDirector
|
SaleOrdinary Shares | 5,000 | $64.83 | $324,155.00 |
DisclosureSEC source: 0001209191-19-041912 · doc4.xml · nonDerivative · entry 2 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,504 F2 · price: On July 10, 2019, Mr. Leung sold 5,000 shares in multiple trades at prices ranging from $64.62 to $65.39. The price reported above reflects the weighted average sale price. Mr. Leung hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:04 UTC |
LEUNG GABRIELDirector
|
Exercise / conversionOrdinary Shares | 5,000 | $3.44 | $17,200.00 |
DisclosureSEC source: 0001209191-19-041912 · doc4.xml · nonDerivative · entry 1 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung. Read SEC document |
| July 05, 2019 Filed Jul 9, 2019 16:25 UTC |
Longsworth Todd ChristopherGeneral Counsel
|
GrantOrdinary Shares | 696 | $27.81 | $19,357.15 |
DisclosureSEC source: 0001209191-19-041559 · doc4.xml · nonDerivative · entry 1 Longsworth Todd Christopher · CIK 0001693530 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,900 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2019 through June 30, 2019. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 28, 2019. Read SEC document |
| July 05, 2019 Filed Jul 9, 2019 20:26 UTC |
Shah PriteshChief Commercial Officer
|
GrantOrdinary Shares | 764 | $27.81 | $21,248.37 |
DisclosureSEC source: 0001209191-19-041560 · doc4.xml · nonDerivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,976 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2019 through June 30, 2019. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 28, 2019. Read SEC document |
| July 05, 2019 Filed Jul 9, 2019 20:23 UTC |
GROENHUYSEN WILHELMUS CMChief Financial Officer
|
GrantOrdinary Shares | 454 | $27.81 | $12,626.65 |
DisclosureSEC source: 0001209191-19-041558 · doc4.xml · nonDerivative · entry 1 GROENHUYSEN WILHELMUS CM · CIK 0001264783 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,179 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2019 through June 30, 2019. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 28, 2019. Read SEC document |
| July 05, 2019 Filed Jul 9, 2019 20:22 UTC |
Danziger AsafDirector · Chief Executive Officer
|
GrantOrdinary Shares | 471 | $27.81 | $13,099.45 |
DisclosureSEC source: 0001209191-19-041555 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,782 F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2019 through June 30, 2019. This transaction is also exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 28, 2019. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:12 UTC |
Danziger AsafDirector · Chief Executive Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 187,500 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001209191-19-040204 · doc4.xml · derivative · entry 3 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,500 Underlying: Ordinary Shares · 187,500 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested and currently exercisable as of the date hereof. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:12 UTC |
Danziger AsafDirector · Chief Executive Officer
|
SaleOrdinary Shares | 187,500 | $62.15 | $11,653,125.00 |
DisclosureSEC source: 0001209191-19-040204 · doc4.xml · nonDerivative · entry 2 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,311 F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:12 UTC |
Danziger AsafDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 187,500 | $7.15 | $1,340,625.00 |
DisclosureSEC source: 0001209191-19-040204 · doc4.xml · nonDerivative · entry 1 Danziger Asaf · CIK 0001654435 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger. Read SEC document |
| June 27, 2019 Filed Jun 28, 2019 22:55 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 11,175 | $60.30 | $673,852.50 |
DisclosureSEC source: 0001209191-19-039541 · doc4.xml · nonDerivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,037 F1 · price: On June 27, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 11,175 shares in multiple trades at prices ranging from $60.02 to $60.97. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 16:01 UTC |
Ambrogi Michael J.Chief Operating Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 110,868 | $0.00 Strike: $22.00 | $0.00 |
DisclosureSEC source: 0001209191-19-038446 · doc4.xml · derivative · entry 3 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,957 Underlying: Ordinary Shares · 110,868 shares Expires 2025-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 16:01 UTC |
Ambrogi Michael J.Chief Operating Officer
|
SaleOrdinary Shares | 110,868 | $60.00 | $6,652,080.00 |
DisclosureSEC source: 0001209191-19-038446 · doc4.xml · nonDerivative · entry 2 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,674 F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 16:01 UTC |
Ambrogi Michael J.Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 110,868 | $22.00 | $2,439,096.00 |
DisclosureSEC source: 0001209191-19-038446 · doc4.xml · nonDerivative · entry 1 Ambrogi Michael J. · CIK 0001654363 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:06 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 12,500 | $0.00 Strike: $11.85 | $0.00 |
DisclosureSEC source: 0001209191-19-038457 · doc4.xml · derivative · entry 3 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 12,500 shares Expires 2027-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:06 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 12,500 | $60.00 | $750,000.00 |
DisclosureSEC source: 0001209191-19-038457 · doc4.xml · nonDerivative · entry 2 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,212 F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 20:06 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOrdinary Shares | 12,500 | $11.85 | $148,125.00 |
DisclosureSEC source: 0001209191-19-038457 · doc4.xml · nonDerivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.